sec filing
QN
NASDAQ · QNCX
Quince Therapeutics, Inc.
Healthcare · Biotechnology
$33.93
Up+$1.82 (+5.67%)
Updated Aug 23, 2026, 11:15 AM
SID Score
5.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 245.56M
- P/E ratio
- -4.2
- Dividend yield
- 0.00%
- 52-week range
- $0.08 – $35.41
- Volume
- 9.54K
- Avg. volume
- 589.45K
Price performance
QNCX price history
1M range · 20 trading sessions · Daily adjusted prices
QNCX closed at $33.93 after 20 trading sessions, up 90.08% for the selected period.
- Last close
- $33.93
- Period change
- +90.08%
- Period low
- $17.85
- Period high
- $34.57
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $32.77 | $34.085 | $32.57 | $33.93 | 9.54K |
| Aug 20, 2026 | $34.57 | $35.15 | $31.62 | $32.11 | 23.33K |
| Aug 19, 2026 | $32.89 | $35.23 | $31.25 | $34.57 | 23.4K |
| Aug 18, 2026 | $33.00 | $34.86 | $32.27 | $32.91 | 28.62K |
| Aug 17, 2026 | $34.95 | $35.41 | $33.08 | $34.12 | 38.99K |
| Aug 14, 2026 | $31.78 | $35.20 | $31.78 | $34.04 | 26.18K |
| Aug 13, 2026 | $30.89 | $33.7371 | $30.89 | $32.41 | 34.48K |
| Aug 12, 2026 | $32.92 | $33.26 | $30.0397 | $31.26 | 44.13K |
| Aug 11, 2026 | $31.50 | $33.11 | $30.5001 | $32.73 | 35.22K |
| Aug 10, 2026 | $30.00 | $31.47 | $29.68 | $30.65 | 33.7K |
| Aug 7, 2026 | $29.92 | $30.77 | $29.25 | $30.20 | 30.36K |
| Aug 6, 2026 | $29.17 | $30.32 | $28.5517 | $29.54 | 26.12K |
| Aug 5, 2026 | $27.16 | $29.99 | $27.16 | $28.88 | 42.79K |
| Aug 4, 2026 | $25.36 | $27.48 | $24.8097 | $27.41 | 26.38K |
| Aug 3, 2026 | $23.505 | $26.615 | $23.50 | $24.965 | 54.41K |
| Jul 31, 2026 | $23.47 | $24.59 | $21.55 | $23.39 | 35.3K |
| Jul 30, 2026 | $21.81 | $23.66 | $21.7647 | $23.03 | 58.79K |
| Jul 29, 2026 | $19.51 | $22.4099 | $18.4269 | $22.00 | 80.5K |
| Jul 28, 2026 | $17.47 | $19.37 | $17.36 | $19.37 | 37.63K |
| Jul 27, 2026 | $17.72 | $18.49 | $17.60 | $17.85 | 18.09K |
Latest QNCX news
The latest Smart Investors Daily articles mentioning QNCX.
Stock researchResearch & News · Competitors
Loading stock research…